Literature DB >> 15596802

Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.

Anne Ahlmann Nielsen1, Annette Balle Sørensen, Jörg Schmidt, Finn Skou Pedersen.   

Abstract

The murine leukemia retrovirus SL3-3 induces lymphomas in the T-cell compartment of the hematopoetic system when it is injected into newborn mice of susceptible strains. Previously, our laboratory reported on a deletion mutant of SL3-3 that induces T-cell tumors faster than the wild-type virus (S. Ethelberg, A. B. Sorensen, J. Schmidt, A. Luz, and F. S. Pedersen, J. Virol. 71:9796-9799, 1997). PCR analyses of proviral integrations in the promoter region of the c-myc proto-oncogene in lymphomas induced by wild-type SL3-3 [SL3-3(wt)] and the enhancer deletion mutant displayed a difference in targeting frequency into this locus. We here report on patterns of proviral insertions into the c-myc promoter region from SL3-3(wt), the faster variant, as well as other enhancer variants from a total of approximately 250 tumors. The analysis reveals (i) several integration site hot spots in the c-myc promoter region, (ii) differences in integration patterns between SL3-3(wt) and enhancer deletion mutant viruses, (iii) a correlation between tumor latency and the number of proviral insertions into the c-myc promoter, and (iv) a [5'-(A/C/G)TA(C/G/T)-3'] integration site consensus sequence. Unexpectedly, about 12% of the sequenced insertions were associated with point mutations in the direct repeat flanking the provirus. Based on these results, we propose a model for error-prone gap repair of host-provirus junctions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596802      PMCID: PMC538719          DOI: 10.1128/JVI.79.1.67-78.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.

Authors:  H W Amtoft; A B Sørensen; C Bareil; J Schmidt; A Luz; F S Pedersen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo.

Authors:  S Ethelberg; A B Sørensen; J Schmidt; A Luz; F S Pedersen
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Distribution of targets for avian retrovirus DNA integration in vivo.

Authors:  E S Withers-Ward; Y Kitamura; J P Barnes; J M Coffin
Journal:  Genes Dev       Date:  1994-06-15       Impact factor: 11.361

4.  Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration.

Authors:  S W Stevens; J D Griffith
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.

Authors:  S Ethelberg; B Hallberg; J Lovmand; J Schmidt; A Luz; T Grundström; F S Pedersen
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity.

Authors:  J A Gäken; M Tavassoli; S U Gan; S Vallian; I Giddings; D C Darling; J Galea-Lauri; M G Thomas; H Abedi; V Schreiber; J Ménissier-de Murcia; M K Collins; S Shall; F Farzaneh
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3.

Authors:  A B Sørensen; M Duch; H W Amtoft; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  The influence of DNA and nucleosome structure on integration events directed by HIV integrase.

Authors:  D Pruss; R Reeves; F D Bushman; A P Wolffe
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

9.  Preferred nucleotide sequence at the integration target site of human T-cell leukemia virus type I from patients with adult T-cell leukemia.

Authors:  K S Chou; A Okayama; I J Su; T H Lee; M Essex
Journal:  Int J Cancer       Date:  1996-01-03       Impact factor: 7.396

10.  Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus.

Authors:  H L Morrison; B Soni; J Lenz
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more
  8 in total

Review 1.  HERVs in neuropathogenesis.

Authors:  Tove Christensen
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-27       Impact factor: 4.147

2.  Activation of an oncogenic microRNA cistron by provirus integration.

Authors:  Clifford L Wang; Bruce B Wang; Gábor Bartha; Lauri Li; Namitha Channa; Mark Klinger; Nigel Killeen; Matthias Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-22       Impact factor: 11.205

3.  Activation of the brain-specific neurogranin gene in murine T-cell lymphomas by proviral insertional mutagenesis.

Authors:  Anne Ahlmann Nielsen; Kristín Rós Kjartansdóttir; Mads Heilskov Rasmussen; Annette Balle Sørensen; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Gene       Date:  2009-04-17       Impact factor: 3.688

4.  Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.

Authors:  Magdalena Julia Dabrowska; Karen Dybkaer; Hans Erik Johnsen; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

5.  In vitro murine leukemia retroviral integration and structure fluctuation of target DNA.

Authors:  Tatsuaki Tsuruyama; Weizhi Liu; Kenichi Yoshikawa
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

6.  Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens.

Authors:  Jeroen de Ridder; Anthony Uren; Jaap Kool; Marcel Reinders; Lodewyk Wessels
Journal:  PLoS Comput Biol       Date:  2006-10-24       Impact factor: 4.475

Review 7.  Hotspots of MLV integration in the hematopoietic tumor genome.

Authors:  T Tsuruyama; T Hiratsuka; N Yamada
Journal:  Oncogene       Date:  2016-11-07       Impact factor: 9.867

8.  Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas.

Authors:  Jinghua Liu; Annette Balle Sørensen; Bruce Wang; Matthias Wabl; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  BMC Mol Biol       Date:  2009-01-21       Impact factor: 2.946

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.